Elser Financial Planning Inc lessened its position in Elevance Health, Inc. (NYSE:ELV – Free Report) by 3.4% during the fourth quarter, Holdings Channel reports. The fund owned 856 shares of the company’s stock after selling 30 shares during the period. Elser Financial Planning Inc’s holdings in Elevance Health were worth $316,000 at the end of the most recent reporting period.
A number of other institutional investors have also added to or reduced their stakes in the company. Raelipskie Partnership bought a new position in shares of Elevance Health during the third quarter valued at about $26,000. PSI Advisors LLC purchased a new stake in Elevance Health in the third quarter worth about $27,000. Eastern Bank purchased a new stake in Elevance Health in the third quarter worth about $31,000. Crews Bank & Trust purchased a new stake in Elevance Health in the fourth quarter worth about $34,000. Finally, Dunhill Financial LLC lifted its holdings in Elevance Health by 57.8% in the third quarter. Dunhill Financial LLC now owns 71 shares of the company’s stock worth $37,000 after buying an additional 26 shares during the period. Institutional investors own 89.24% of the company’s stock.
Wall Street Analyst Weigh In
Several analysts have commented on ELV shares. Barclays raised their price objective on shares of Elevance Health from $501.00 to $512.00 and gave the stock an “overweight” rating in a report on Friday, January 24th. Cantor Fitzgerald restated an “overweight” rating and issued a $485.00 price objective on shares of Elevance Health in a report on Friday, January 24th. TD Cowen decreased their target price on shares of Elevance Health from $589.00 to $484.00 and set a “buy” rating for the company in a research note on Monday, October 21st. Mizuho decreased their target price on shares of Elevance Health from $585.00 to $505.00 and set an “outperform” rating for the company in a research note on Tuesday, November 5th. Finally, Argus reaffirmed a “hold” rating and set a $405.40 target price on shares of Elevance Health in a research note on Wednesday, January 29th. Three analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $517.03.
Elevance Health Trading Up 0.2 %
NYSE:ELV opened at $391.23 on Monday. The company has a current ratio of 1.45, a quick ratio of 1.50 and a debt-to-equity ratio of 0.71. Elevance Health, Inc. has a 12 month low of $362.21 and a 12 month high of $567.26. The company has a market cap of $90.73 billion, a PE ratio of 15.28, a price-to-earnings-growth ratio of 1.17 and a beta of 0.83. The company has a 50 day simple moving average of $385.87 and a two-hundred day simple moving average of $453.37.
Elevance Health (NYSE:ELV – Get Free Report) last posted its earnings results on Thursday, January 23rd. The company reported $3.84 EPS for the quarter, topping analysts’ consensus estimates of $3.80 by $0.04. Elevance Health had a net margin of 3.38% and a return on equity of 18.28%. Research analysts forecast that Elevance Health, Inc. will post 34.05 earnings per share for the current year.
Elevance Health Increases Dividend
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 25th. Stockholders of record on Monday, March 10th will be paid a dividend of $1.71 per share. This represents a $6.84 annualized dividend and a dividend yield of 1.75%. The ex-dividend date of this dividend is Monday, March 10th. This is a boost from Elevance Health’s previous quarterly dividend of $1.63. Elevance Health’s dividend payout ratio (DPR) is currently 25.46%.
Elevance Health Company Profile
Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.
See Also
- Five stocks we like better than Elevance Health
- What Are Dividend Achievers? An Introduction
- 3 Volatility ETFs to Help You Profit from Market Chaos
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Lam Research: Is a NAND Upgrade Cycle the Next Growth Catalyst?
- With Risk Tolerance, One Size Does Not Fit All
- Chipotle’s Slip: A Short-Term Dip or Long-Term Opportunity?
Want to see what other hedge funds are holding ELV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Elevance Health, Inc. (NYSE:ELV – Free Report).
Receive News & Ratings for Elevance Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elevance Health and related companies with MarketBeat.com's FREE daily email newsletter.